Pierangelo Spedini

Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi

Luca Arcaini, Daniele Vallisa, Sara Rattotti et al. · Annals of Oncology · 2014 · 169 citations · Full text

Lymphoid Neoplasia, Antiviral Treatment, Viral Hepatitis +8

Delayed-onset peripheral blood cytopenia after rituximab: Frequency and risk factor assessment in a consecutive series of 77 treatments

Chiara Cattaneo, Pierangelo Spedini, Salvatore Casari et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2006 · 114 citations

Prospective Phase II Study on 5-Days Azacitidine for Treatment of Symptomatic and/or Erythropoietin Unresponsive Patients with Low/INT-1–Risk Myelodysplastic Syndromes

Carla Filì, Michele Malagola, Matilde Y. Follo et al. · Clinical Cancer Research · 2013 · 68 citations · Full text

Risk-oriented postremission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groups

Renato Bassan, Enrico Pogliani, Paolo Casula et al. · The Hematology Journal · 2001 · 32 citations

Hematological Malignancy, Standard-risk Class, Oncology +12

Bleeding Tendency of Unknown Origin and Protein Z Levels

G Gamba, Giampiera Bertolino, Nadia Montani et al. · Thrombosis Research · 1998 · 30 citations

Thrombosis, Medicine, Pathogenesis +11